Watch the latest episode of focusIR Fireside Chats: Why Edinburgh Investment Trust Is Backing Turnaround Stocks for 2026 Growth. View here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksJourneo Regulatory News (JNEO)

Share Price Information for Journeo (JNEO)

Share Price is delayed by 15 minutes
Get Live Data
450.00    -5.00 (-1.10%)
Bid:
440.00
Ask:
460.00
Spread: 20.00 (4.545%)
Market Cap: £79.54m
JNEO Live PriceLast checked at - London Stock Exchange

Intraday Journeo Share Chart

Total Voting Rights

30 Apr 2012 07:00

RNS Number : 2526C
21st Century Technology PLC
30 April 2012
 



 

21st Century Technology plc

 

("21st Century" or "the Company")

 

 

Total Voting Rights

 

For the purposes of the Financial Services Authority's Disclosure and Transparency Rules, the Company announces that as at 30 April 2012 the total number of ordinary shares of 10p in issue is 92,539,755, with each share carrying the right to one vote.

 

The Company has no ordinary shares held in treasury. The total number of voting rights in the Company is therefore 92,539,755. This figure may be used by shareholders in the Company as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change to their interest in, the share capital of the Company under the FSA's Disclosure and Transparency Rules.

 

Enquiries:

 

21 Century Technology plc

Wilson Jennings

Tel: 020 8710 4016

www.21stplc.com

Finance Director

Daniel Stewart & Company plc (Nomad & Broker)

Noelle Greenaway

Tel: 020 7776 6550

MHP Communications

Barnaby Fry/Vicky Watkins

Tel: 020 3128 8100

 

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
TVRBBGDSDBDBGDR
Date   Source Headline
3rd Apr 20237:00 amRNSEast Midlands Airport
31st Mar 20237:00 amRNSContract Win
28th Mar 20237:01 amRNSContract Awards
28th Mar 20237:00 amRNSFinal Results
23rd Mar 20237:00 amRNSGatwick Airport Contract
21st Mar 20237:00 amRNSAppointment of Independent Non-executive Director
20th Mar 20237:00 amRNSPurchase Order
10th Mar 20237:00 amRNSPurchase Order
8th Mar 20237:00 amRNSContract Win
9th Feb 20237:00 amRNSTrading Update
31st Jan 20234:39 pmRNSTotal Voting Rights
26th Jan 20231:22 pmRNSHolding(s) in Company
24th Jan 20239:40 amRNSHolding(s) in Company
23rd Jan 202311:18 amRNSHolding(s) in Company
19th Jan 20237:00 amRNSHolding(s) in Company
18th Jan 20234:58 pmRNSHolding(s) in Company
18th Jan 20232:08 pmRNSHolding(s) in Company
18th Jan 202310:13 amRNSHolding(s) in Company
17th Jan 202311:41 amRNSHolding(s) in Company
17th Jan 202311:37 amRNSHolding(s) in Company
16th Jan 20238:00 amRNSDirector/PDMR Shareholdings
13th Jan 202311:53 amRNSResult of General Meeting
5th Jan 20231:48 pmRNSResult of Retail Offer
23rd Dec 20227:00 amRNSPurchase Order
22nd Dec 20227:15 amRNSRetail Offer
22nd Dec 20227:00 amRNSAcquisition of IGL Limited and Fundraising
19th Dec 20227:00 amRNSContract Award
5th Dec 20227:00 amRNSPurchase Order
19th Sep 20227:00 amRNSDublin Airport Agreement
5th Sep 20227:00 amRNSHalf-year Report
1st Aug 20227:00 amRNSTrading Update and Contract Win
21st Jul 20227:00 amRNSPurchase Order
8th Jun 20227:00 amRNSContract Awards
21st Apr 202212:30 pmRNSResult of AGM
8th Apr 20227:00 amRNSFirst Bus £9m Framework Agreement
29th Mar 20222:59 pmRNSPosting of Annual Report and Notice of AGM
28th Mar 20227:00 amRNSFinal Results
25th Mar 20227:00 amRNSRenewal of Exclusive Distribution Agreement
1st Mar 20227:00 amRNSPurchase Order
2nd Feb 20225:32 pmRNSHolding(s) in Company
1st Feb 20227:00 amRNSChange of Adviser
31st Jan 20227:00 amRNSTrading Update
31st Jan 20227:00 amRNSRail systems framework services agreement
23rd Dec 20217:00 amRNSLoan Note Extension
7th Dec 20217:00 amRNSFramework agreement contract extension
6th Dec 20217:00 amRNSContract Award
24th Nov 20217:00 amRNSSoftware as a Service contract
8th Oct 20217:00 amRNSFramework Agreement
27th Sep 20217:00 amRNSHalf-year Report
15th Sep 20217:00 amRNSContract Award

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.